Definitive Contract W81K0019C0005

Award Date 10/1/19
Potential Completion Date 9/30/22
Potential Value $1.2M
Federal Agency
Medical Command
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
El Paso, TX 79918, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of the Army Medical Command awarded a $177,482.40 firm fixed price delivery order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The contract is for the provision of test reagents and has a completion date of September 30, 2022. Roche has previously received other federal contract awards, including Indefinite Delivery Contracts and Blanket Purchase Agreements, to supply a range of medical...
This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for the delivery of required reagents to the Department of the Army Medical Command. The $2,676,584.59 firm fixed price delivery order contract has a completion date of September 30, 2018 and was awarded on April 10, 2017. The contract is not designated as a set-aside. Roche Diagnostics is a foreign-owned, for-profit manufacturer and distributor of in vitro diagnostics, reagents, laboratory...
The Department of the Army Medical Command awarded a $921,898.03 firm-fixed-price definitive contract to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, to provide reagents. The contract has a completion date of September 30, 2019 and was not set aside. The original solicitation was for an automated clinical chemistry and immunodiagnostic testing system, including analyzers, training, reagents, supplies, and preventative maintenance. Through this contract, Roche...
The Department of the Army Medical Command awarded a firm fixed-price delivery order contract to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The $1,280,000.00 contract is for histology cost-per-test services to be provided to the Brooke Army Medical Center, with a completion date of September 30, 2018. Roche Diagnostics has provided similar medical equipment and supplies to various federal agencies through...
This is a federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the provision of reagents and peripheral supplies. The contract was awarded by the Defense Health Agency, is a Blanket Purchase Agreement (BPA) Call with a firm fixed price, and has a potential value of $2,238,187.65. The contract has no set-aside designation. Roche Diagnostics is a foreign-owned, for-profit organization that manufactures in vitro diagnostics, reagents, laboratory...
This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for the supply of ROCHE COBAS products. The contract, valued at $150,371.25, is a firm fixed-price purchase order awarded by the Department of the Army Medical Command. The contract does not have a set-aside designation. Roche Diagnostics is a foreign-owned, for-profit organization that manufactures in vitro diagnostics, reagents, laboratory instruments, and associated products and...
The Department of the Air Force Materiel Command awarded a $118,480.85 firm fixed-price delivery order to Roche Diagnostics Corporation for in vitro diagnostic substances, reagents, test kits, and sets. The contract does not have a set-aside designation. Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is a foreign-owned, for-profit manufacturer of laboratory instruments, equipment, and supplies. Roche holds multiple General Services Administration (GSA) Schedule...
The Department of the Air Force Materiel Command awarded a Blanket Purchase Agreement (BPA) call to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $616,868.59 firm-fixed-price contract is for the provision of reagents and consumables, with a completion date of February 14, 2019. Roche Diagnostics has extensive experience as a prime contractor and subcontractor providing medical equipment, supplies, and...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a purchase order contract to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned for-profit manufacturer. The $161,459.20 firm-fixed-price contract is for the annual requirement of VENTANA reagents, with a completion date of January 12, 2021. Roche Diagnostics is a provider of in vitro diagnostics, reagents, laboratory instruments, and associated products and services to various...
This is a delivery order awarded under contract W81K0221D0007 by the Defense Health Agency (DHA) to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp. The order is for the delivery of Roche reagents for the period of October 1, 2024 to September 30, 2025, with a ceiling value of $354,964.92. This order is not set aside for any specific business program. Roche Diagnostics is a large, foreign-owned manufacturer and distributor of in vitro diagnostics, reagents, and laboratory...

The Department of the Army Medical Command awarded a firm-fixed-price definitive contract to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the provision of cancer antibody reagents. The $1,193,284.11 contract, which does not have a set-aside designation, is for the delivery of these supplies to the William Beaumont Army Medical Center in El Paso, Texas. Roche Diagnostics is a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, laboratory instruments, and related products and services. The contract was awarded on October 1, 2019, with a completion date of September 30, 2022. Roche Diagnostics has previously received awards from various federal agencies, including the Department of Veterans Affairs, Department of Defense, and Department of Health and Human Services, to provide critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services.

Generated 3/22/24, 3:04 PM